Maria Roussakis: It is an Honour to Be a Part of the ISBT Young Professionals Council
Maria Roussakis, Lecturer (Medical Laboratory Science) at the University of Southern Queensland, reposted from ISBT on LinkedIn:
”Thank you to all young professionals and mentors that attended yesterday’s ISBT Young Professional’s Breakfast.
It was great to see everyone have lively discussions and network with each other!
It is an honour to be a part of the ISBT Young Professionals Council to help organise events that bring together young professionals within the field of blood transfusion!”
Quoting International Society of Blood Transfusion (ISBT)‘s post:
”Day 1 of Blood 2025 and ISBT Perth 2025 has set the tone for an inspiring congress ahead, filled with science, connection, and innovative ideas.
The congress kicked off with the Young Professionals Breakfast which brought professionals from around the world together to build lasting connections.
Then it was time for engaging sessions tackling key questions in transfusion medicine, such as the role of AI and the current clinical challenges that we are facing.
Once the sessions were over it was time to come together and connect with delegates, corporate partners, sponsors and regional societies at the welcome reception.
Don’t forget to stop by the ISBT booth and say hello to the team!
Blood 2025 and ISBT Perth 2025 is just getting started!
What are you most excited about at the congress?”
Stay updated with Hemostasis Today.
-
Oct 27, 2025, 12:12Maria Roussakis: It is an Honour to Be a Part of the ISBT Young Professionals Council
-
Oct 27, 2025, 05:47Ahmed Koriesh on The Novel Approach in Use of Tenecteplase
-
Oct 27, 2025, 04:42Louise Breslin: Exciting Results in The CRYPTICS Trial
-
Oct 26, 2025, 16:55ECTH 2025: 3 Unforgettable Days of Science and Shared Purpose
-
Oct 26, 2025, 16:35Ahmed Koriesh on Thrombolysis in Stroke Patients on DOACs
-
Oct 27, 2025, 13:00Hossam El Benawi Shares Multi Site LVT Study from Mayo Clinic
-
Oct 27, 2025, 08:01Acquired Hemophilia A (AHA) is Rare and Often Missed - RPTH Journal
-
Oct 27, 2025, 05:00Wolfgang Miesbach on WFH Guidelines Covering FDA/EMA-Approved AAV Gene Therapy for Hemophilia
-
Oct 26, 2025, 15:04Nita Radhakrishnan and Colleagues on Inherited Haematological Conditions
-
Oct 26, 2025, 14:55Anirban Sen Gupta on Biosynthetic Blood Surrogates Current State-of-Art
-
Oct 25, 2025, 07:42Adithya Hande: India’s Silent Killer and a Scientific Breakthrough
-
Oct 23, 2025, 09:57Arun V. J: Artificial Blood Is Closer Than You Think
-
Oct 23, 2025, 07:11Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
-
Oct 23, 2025, 07:05Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
-
Oct 22, 2025, 08:25Johanna Nystedt: Not Every Day We Can Release a New Blood Product to Meet An Unmet Medical Need!
-
Oct 27, 2025, 13:18Stroke Foundation Welcomes Jacqui McCallum as the New Executive Director
-
Oct 27, 2025, 12:54Guillermo Lahera Forteza on Stroke and Mental Health
-
Oct 27, 2025, 12:37Joshua Ngimbwa Recognised as the Best Male Junior Investigator Awardee at the Tanzania Health Summit
-
Oct 27, 2025, 08:00Rohit Gosain: Revumenib is Now FDA Approved for R/R AML with NPM1 Mutation
-
Oct 27, 2025, 06:30Andres Ricaurte Fajardo on CVT Experience from a Latin American Cohort